Lukas Binder

ORCID: 0000-0003-4309-9808
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Liver Disease Diagnosis and Treatment
  • Gut microbiota and health
  • Liver Disease and Transplantation
  • Biosimilars and Bioanalytical Methods
  • Gastroesophageal reflux and treatments
  • Alcohol Consumption and Health Effects
  • Clostridium difficile and Clostridium perfringens research
  • Gastrointestinal disorders and treatments
  • Immunodeficiency and Autoimmune Disorders
  • Fatty Acid Research and Health
  • Potassium and Related Disorders
  • Renal function and acid-base balance
  • Eosinophilic Esophagitis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer therapeutics and mechanisms
  • Pharmaceutical Economics and Policy
  • Metastasis and carcinoma case studies
  • Pharmacological Effects of Natural Compounds
  • Liver Diseases and Immunity
  • Celiac Disease Research and Management
  • Genital Health and Disease
  • Chronic Lymphocytic Leukemia Research
  • Esophageal and GI Pathology

Medical University of Graz
2014-2025

Medical University of Vienna
2023

Taipei Institute of Pathology
2015

Forschungs- und Beratungsstelle Arbeitswelt
2008

High-density lipoprotein cholesterol (HDL-C) levels are reduced in patients with chronic liver disease and inversely correlate severity. During acute conditions such as sepsis, HDL-C decrease rapidly HDL particles undergo profound changes their composition function. We aimed to determine whether indices of quantity quality associate progression survival advanced disease.

10.1016/j.jhep.2020.01.026 article EN cc-by-nc-nd Journal of Hepatology 2020-02-14

The SALVE Histopathology Group (SHG) developed and validated a grading staging system for the clinical full histological spectrum of alcohol-related liver disease (ALD) evaluated its prognostic utility in multinational cohort 445 patients.SALVE grade was described by semiquantitative scores steatosis, activity (hepatocellular injury lobular neutrophils) cholestasis. diagnosis steatohepatitis due to ALD (histological ASH, hASH) based on presence hepatocellular ballooning neutrophils. Fibrosis...

10.1016/j.jhep.2021.05.029 article EN cc-by Journal of Hepatology 2021-06-11

Anti-TNF antibodies were the first biologic treatment option for patients with inflammatory bowel diseases.To assess length of persistence anti-TNF therapy and influencing factors used in standard care diseases.Single-centre, retrospective study from a register including who received last 20 years at centre. Kaplan-Meier analysis log-rank test was to describe persistence. With multivariable Cox regression analysis, risk failure investigated.Five hundred thirty-eight (CD, Crohn's disease:...

10.1111/apt.16478 article EN cc-by-nc Alimentary Pharmacology & Therapeutics 2021-06-20

Abstract The gut microbiome contributes to chronic inflammatory responses in ulcerative colitis (UC), but molecular mechanisms and disease-relevant effectors remain unclear. Here we analyze the pro-inflammatory properties of colonic fluid obtained during colonoscopy from UC control patients. In patients with UC, find that pelletable effector fraction is composed mostly bacterial extracellular vesicles (BEVs) exhibit high IgA-levels incite strong IgA receptor-positive (CD89 + ) immune cells....

10.1038/s41467-025-59354-5 article EN cc-by Nature Communications 2025-04-29

Abstract Background The fecal microbiome of patients with inflammatory bowel diseases (IBD) is characterized by longitudinal variability. It remains unknown if this caused decreased resilience the to external factors. We investigated influence osmotic diarrhea induced preparation as a disruptive factor on in IBD and healthy comparators. Methods conducted prospective, single-center study including controls scheduled for colonoscopy uniform preparation. Fecal samples were collected at 7 time...

10.1093/ibd/izaf053 article EN Inflammatory Bowel Diseases 2025-04-29

Abstract Background Corticosteroids are used for induction of remission in patients with moderately to severely active ulcerative colitis. However, up one-third fail this therapy. We investigated if fecal microbial composition or its metabolic capacity associated response systemic corticosteroids. Methods In prospective, multicenter study, colitis (Lichtiger score ≥4) receiving corticosteroids were eligible. Data assessed and samples collected before after 4 weeks treatment. Patients divided...

10.1093/ibd/izad126 article EN cc-by Inflammatory Bowel Diseases 2023-07-18

The incidence of sexually transmitted infections (STIs) is unbridled and on the rise. Extragenital STIs (anal pharyngeal infections) are commonly asymptomatic, resulting in delayed diagnosis treatment consequently higher chances onward transmission.

10.1111/jdv.20029 article EN cc-by-nc Journal of the European Academy of Dermatology and Venereology 2024-04-12

In April 2020 during the coronavirus disease 2019 (COVID-19) pandemic, a 41-year-old female presented to emergency department with recurrent vomiting and abdominal pain that had been ongoing for 2 days haematemesis present several hours. The past medical history was unremarkable, except bariatric gastric bypass surgery performed in 2016. During detailed inquiry, patient reported she intentionally taken 10 ml of ethanol-containing hand disinfectant orally each day period of> 3 weeks fear...

10.1111/his.14137 article EN cc-by-nc-nd Histopathology 2020-05-07

Among patients with ulcerative colitis, 30-50% receive corticosteroids within the first five years after diagnosis. We aimed to reconsider their effectiveness in context of biologic era.In this prospective, multicenter study, active colitis (Lichtiger score ≥ 4) were eligible if initiating systemic corticosteroids. The primary endpoint was clinical response (decrease Lichtiger ≥50%) at week 4. Secondary endpoints included combined defined as and any reduction elevated biomarkers (CRP and/or...

10.3390/jcm12144853 article EN Journal of Clinical Medicine 2023-07-24

An elderly female patient was admitted to intensive care for prolonged vasopressor therapy and mechanical ventilation after cardiac arrest acute percutaneous coronary intervention. Antiplatelet, thyroid hormone replacement statin therapies were administered through a 14-French nasogastric tube (Nestlé Health Science) enteral feeding initiated. Correct position of the confirmed radiologically. On seventh day in care, our seen regurgitate soft crumbs into her mouth. The blocked removed, but...

10.1136/gutjnl-2017-315619 article EN Gut 2018-01-05

Background and aims Immunological treatment failure of anti-TNF therapy negatively influences persistence a second in IBD patients. So far it is unknown if this effect also observed for other monoclonal antibodies. We assessed the influence immunogenicity to anti-TNFs on subsequent ustekinumab vedolizumab therapy.Methods patients with without (undetectable trough levels antibody titers ≥20 ng/mL) (UST) and/or (VDZ) were included retrospective, single-center study. The Kaplan-Meier method...

10.1080/00365521.2022.2088248 article EN Scandinavian Journal of Gastroenterology 2022-06-22

Histological subclassification of cirrhosis may allow for the definition severe fibrosis stages with different clinical severity and prognosis. However, value histological staging is limited by intra- interobserver variability. We therefore aimed to determine relationship between morphometrically quantified measured as collagen proportionate area …

10.1093/alcalc/agv079.19 article EN Alcohol and Alcoholism 2015-09-01

Background The gut microbiome of patients with inflammatory bowel diseases (IBD) is characterized by increased longitudinal variability. It remains unknown if this caused instability the to external factors. We investigated influence osmotic diarrhea induced preparation as an source irritation on in IBD and healthy comparators.

10.1055/s-0043-1769025 article EN Zeitschrift für Gastroenterologie 2023-05-01

Due to constantly rising therapy costs, biosimilars and generic drugs have gained tremendous importance through recent decades. Nevertheless, the acceptance among healthcare workers regarding in previously published international studies is considerably lower than scientific data on equivalent safety efficacy would suggest. The aim of this questionnaire-based survey was determine perception knowledge by medical professionals from different facilities Vienna, Austria.

10.1007/s00228-023-03603-3 article EN cc-by European Journal of Clinical Pharmacology 2023-12-22

Hintergrund und Ziele Systemischen Kortikosteroide sind eine wichtige Substanzgruppe in der Behandlung aktiven Colitis ulcerosa (CU). Das Ansprechen auf medikamentöse Therapien wie Biologika wird mutmaßlich durch das Darmmikrobiom beeinflusst. Wir untersuchten ob die Zusammensetzung Funktion des Mikrobioms bei Patienten mit aktiver CU auch Zusammenhang dem Therapieansprechen steht.

10.1055/s-0042-1755726 article DE Zeitschrift für Gastroenterologie 2022-08-01

Abstract Background Anti-TNF therapy is still the most frequently used first-line biologic treatment in inflammatory bowel disease (IBD). This study aimed to determine length of persistence and describe reasons for discontinuation anti-TNF standard care IBD patients. Methods A single-center, real-world, retrospective including patients (Crohn’s (CD), ulcerative colitis (UC), unclassified (IBD-U)), who received an last 20 years at center, was conducted. Length therapy, differences duration...

10.1093/ecco-jcc/jjab076.548 article EN Journal of Crohn s and Colitis 2021-05-01
Coming Soon ...